VF
MRKR icon

Virtu Financial’s Marker Therapeutics MRKR Stock Holding History

Virtu Financial’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17K Buy
+11,574
New +$16.9K ﹤0.01% 1367
2025
Q4 		– Sell
-28,329
Closed -$25K – 2024
2025
Q3 		$25K Buy
+28,329
New +$35K ﹤0.01% 1251
2023
Q3 		– Sell
-20,472
Closed -$63K – 1661
2023
Q2 		$63K Buy
+20,472
New +$35.6K ﹤0.01% 1107
2022
Q4 		– Sell
-2,000
Closed -$7K – 1956
2022
Q3 		$7K Buy
2,000
+349
+21% +$1.28K ﹤0.01% 1553
2022
Q2 		$5K Buy
+1,651
New +$5.49K ﹤0.01% 1461
2022
Q1 		– Sell
-1,303
Closed -$12K – 1820
2021
Q4 		$12K Sell
1,303
-3,231
-71% -$42.9K ﹤0.01% 1562
2021
Q3 		$77K Buy
+4,534
New +$92.9K 0.01% 1205
2021
Q1 		– Sell
-7,622
Closed -$111K – 1870
2020
Q4 		$111K Buy
7,622
+3,399
+80% +$52.8K 0.01% 1032
2020
Q3 		$63K Buy
4,223
+2,991
+243% +$54.6K 0.01% 787
2020
Q2 		$26K Buy
+1,232
New +$26.9K ﹤0.01% 1107
2019
Q4 		$88K Buy
3,059
+690
+29% +$25.1K 0.01% 1107
2019
Q3 		$121K Buy
+2,369
New +$140K 0.01% 1052

Other funds holding MRKR

BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Virtu Financial's MRKR Position: Q2 2026 in Review

Virtu Financial opened a new position in Marker Therapeutics (MRKR) in Q2 2026: 11,574 shares worth $17K. The stake represents ﹤0.01% of the portfolio and ranks #1367 among its holdings. This is a return to the name: Virtu Financial previously reported a position in MRKR as recently as Q3 2025.

Virtu Financial first reported a position in MRKR in Q3 2019 and has held it in 12 quarters since. The position peaked at $121K in Q3 2019. 25 funds tracked by Wall St. Rank hold MRKR as of Q2 2026.

  • Virtu Financial held 11,574 shares of Marker Therapeutics worth $17K as of Q2 2026.
  • Marker Therapeutics was a new Virtu Financial position in Q2 2026.
  • Marker Therapeutics made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1367 holding.
  • Virtu Financial first reported a position in Marker Therapeutics in Q3 2019 and has held it in 12 quarters since.
  • Virtu Financial's Marker Therapeutics position peaked at $121K in Q3 2019.
  • 25 funds tracked by Wall St. Rank held Marker Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.